A Clinical Study to Evaluate the Efficacy and Satisfaction of the Skinceuticals Skin Care Product (CE) for Skin Repair Post Fraxel Laser Treatment

Inclusion Criteria: 1. Chinese subjects aged 18-65 years (inclusive); 2. Subjects with Fitzpatrick skin type II-IV; 3. Subjects with consistent facial skin status on both sides and planned to receive fraxel laser treatment; 4. Subjects are willing to follow the requirements of the study protocol and complete the corresponding procedures; 5. Subjects understand the nature of the study and sign the informed consent form (ICF). Exclusion Criteria: 1. Subjects with photosensitive skin or photosensitization-related diseases; 2. Subjects with a history of skin pigmentation, such as pigmentation caused by sex hormone factors (pregnancy, oral contraceptives); 3. Subjects with hypertrophic scar or scar constitution; 4. Subjects with autoimmune diseases, endocrine diseases or liver diseases that may lead to skin color changes; 5. Subjects who have received steroid/phototoxic drugs or laser treatment on the face within 3 months before enrollment; 6. Subjects with a history of sun exposure within 2 weeks prior to enrollment; 7. Subjects who are known to be contraindicated to fraxel laser therapy or CE (or allergic to other skin care components); 8. Subjects with known infection and inflammation in the intended treatment site; 9. Female subjects who are pregnant, lactating or plan to become pregnant; 10. Subjects who plan to use other drugs affecting skin color or intend to undergo other laser therapy and sunbathing during the treatment; 11. Subjects who are participating in other drug or medical device clinical trials; 12. Other subjects who are not suitable for this study as assessed by the investigator